This Week's Financial Market Snapshot. 📸📈
Overview
→ Investors will be looking to build on last week's gains, with the S&P 500 having snapped a four-week losing streak.
→ Speeches by Fed officials, including New York Fed President John Williams, will be monitored for insights into monetary policy outlook and economic assessments.
→ Futures are up as investors anticipate a more targeted approach to US tariffs set to be implemented on April 2.
→ Reports suggest that the Trump administration may exempt certain sectors, boosting market sentiment.
→ The PCE data, the Federal Reserve's preferred inflation gauge, will be closely watched for signs of persistent price pressures.
→ Market participants are increasingly wary of stagflation risks amid softening labor market conditions and accelerating inflation.
Notable Earnings
→ Monday, Mar 24: $LUNR, $OKLO, $KBH
→ Tuesday, Mar 25: $MKC, $GME, $SURG
→ Wednesday, Mar 26: $DLTR, $CHWY, $MVS, $VRNT
→ Thursday, Mar 27: $SNX, $LULU, $KULR, $BRZE
→ Friday, Mar 28: $IPA, $XOS
Economic Data Releases
→ Monday, Mar 24: Manufacturing PMI, Services PMI
→ Tuesday, Mar 25: CB Consumer Confidence, New Home Sales
→ Wednesday, Mar 26: Durable Goods Orders (MoM), Crude Oil Inventories
→ Thursday, Mar 27: GDP (QoQ), Initial Jobless Claims
→ Friday, Mar 28: Core PCE Price Index
Pre-Market Movers 📰📊
$SGMO: Down 55.1% after Pfizer ended their hemophilia A gene therapy co-development, delaying market prospects; $PFE up slightly.
$COIN, $MARA, $RIOT, $MSTR: Up 2.8%-4.6% as Bitcoin jumped back above $95,000.
$VRSN: Up 2.5% after Berkshire Hathaway revealed it purchased 76,487 more shares, totaling $15.6M in the past three trading days; $BRKB up slightly.
$TSLA: Up 1.5%, rebounding after a 3-day dip. Shares surged 21% in December and are up 68% for the year.
$SMCI: Up 1.1% after Monday’s 4% drop, its worst in the S&P 500. Shares are still up 8% this year despite a 6% monthly dip.
$NVDA: Up 1%, building on Monday’s 0.4% rise as the sole Dow gainer. The stock continues to show resilience.
$EQT: Up <1% as after closing a $3.5B Blackstone joint venture, paying down debt. The stock has risen 27% this quarter.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Pre-Market Movers 📰📊
$RGTI: Down 6.4%, reversing Friday’s rally; the quantum stock remains up over 1,600% YTD.
$KULR: Down 4.5%, giving up gains after last week’s 58% surge and announcing a $21M bitcoin purchase.
$MSTR: Down 4.4% after raising $209M through share sales to fund the purchase of 2,100+ bitcoins.
$VVX: Up 4.2% after securing a $170M DEA contract to support the agency’s aircraft fleet.
$PLTR: Down 3.6% after extending a $619M army contract; remains up 361% YTD and 18% this month.
$BA: Down 3.5% as South Korea ordered inspections of B737-800 planes following a deadly Jeju Air crash, the nation’s worst air accident.
$RCAT: Up 2.4% as shares recover from Friday’s slide; up 380% this quarter amid renewed interest in drone stocks.
$VRSN: Up 1.5% after Berkshire Hathaway revealed it purchased 140,000+ shares of the domain registry service.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Pre-Market Movers 📰📊
$KULR: Up 12.3% following a 40% surge on Bitcoin purchase worth $21M, its first since announcing a treasury initiative.
$RGTI, $QUBT, $QBTS: Up 9.4%, 6.2%, and 5.5%, respectively, as quantum computing stocks surged on continued year-end momentum for the growing industry.
$RCAT: Up 5.1%, bolstering a 1,424% YTD gain as drone interest rises and it partners with Palantir.
$AMED: Up 4.6% after extending merger deadline with United Healthcare due to ongoing litigation; $UNH remains flat.
$HMC: Up 2.5% after merger talks with Nissan began, contributing to a 19% weekly gain.
$TM: Up 2.1%, extending a 9% surge, as reports revealed plans to double its return on equity to 20%.
$GME: Down 1.6%, breaking a five-day winning streak, though shares are up 88% year-to-date.
$MSTR: Up 1% as Bitcoin rose above $96K after Thursday's crypto market pressure.
$NFLX: Down 1% despite record NFL streaming viewership, with two games becoming the most streamed in U.S. history.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Market Recap📈📉
$TRAW: Up 150.4% after its bird flu treatment showed safety in a Phase 1 trial, with Phase 2 set for early next year.
$DESP: Up 32.8% after Prosus agreed to buy the platform for $19.50 per share in a $1.7 billion deal closing in Q2 2025.
$HMC: Up 12.8% following merger talks with Nissan, aiming to conclude discussions by June 2025.
$XRX: Up 12.6% on announcing a $1.5 billion acquisition of printer maker Lexmark, closing in the second half of 2025.
$MSTR: Down 8.8% after selling 1.3 million shares to buy 5,262 bitcoins, marking its Nasdaq 100 debut.
$AVGO: Up 5.5%, extending its December rally with shares gaining 41% this month, boosting its 2024 increase above 105%.
$NVO: Up 4.6%, rebounding after an 18% drop Friday due to disappointing trial results for its weight-loss drug CagriSema.
$JWN: Down 1.6% after announcing a $6.25 billion buyout deal with shareholders to receive $24.25 per share in cash.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Pre-Market Movers 📰📊
$TRAW: Up 123.5% on successful phase 1 trial results for H5N1 bird flu treatment, with phase 2 trials set for next year.
$DESP: Up 32.8% after Prosus agreed to acquire the company for $19.50 per share in a $1.7 billion deal.
$HMC: Up 13.9% as merger talks with Nissan officially began, with plans to conclude discussions by June 2025.
$XRX: Up 8.5% following its $1.5 billion acquisition of printer maker Lexmark, boosting investor confidence.
$IMCR: Up 5.9% after dosing its first patient with experimental immunotherapy treatment IMC-0115C.
$NVO: Up 4.4% after rebounding from an 18% loss, despite late-stage trial results for weight-loss drug CagriSema missing expectations.
$TSLA: Up 2.3% premarket, recovering from a 3.5% weekly drop, its worst since the U.S. presidential election.
$OXY, $SIRI, $VRSN: Up 1.6%-2.5% as Berkshire Hathaway increased stakes in all three stocks last week; $BRKB remained flat.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
🚨 CFPB Sues Major Banks Over Zelle Fraud. 🚨
Overview
➡️ The Consumer Financial Protection Bureau (CFPB) has initiated a significant lawsuit against $JPM, $BAC, $WFC, and the operator of Zelle, Early Warning Services.
➡️ This legal action stems from allegations that these institutions failed to adequately protect consumers from rampant fraud on the Zelle payment platform, resulting in losses exceeding $870 million since Zelle's launch in 2017.
Key Allegations
➡️ The CFPB claims that the banks rushed to launch Zelle to compete with other payment apps like Venmo and Cash App without implementing essential consumer protections.
➡️ This negligence allowed scammers to exploit the platform effectively.
➡️ The lawsuit asserts that the banks did not properly investigate fraud complaints or offer necessary reimbursements to victims.
➡️ Many customers were reportedly told to contact the fraudsters directly for recovery of their funds.
➡️ The CFPB alleges violations of the Consumer Financial Protection Act and the Electronic Fund Transfer Act, indicating that the banks failed to conduct reasonable investigations into reported errors and frauds related to Zelle transactions.
Significance of the Lawsuit
➡️ By targeting major banks and a widely used payment system, the CFPB aims to hold these entities accountable for their role in consumer protection failures.
➡️ If successful, this lawsuit could lead to stricter regulations and enhanced security measures for peer-to-peer payment systems, potentially reshaping how such platforms operate and how banks manage fraud prevention.
➡️ The timing of the lawsuit has prompted some criticism from Zelle representatives who argue that it may be politically motivated.
➡️ They contend that Zelle has implemented strong anti-fraud measures and that the lawsuit could ultimately harm consumers by increasing costs and limiting competition among payment services.
Conclusion
➡️ The CFPB's legal action against JPMorgan Chase, Bank of America, Wells Fargo, and Early Warning Services represents a critical moment in consumer financial protection.
➡️ It highlights ongoing concerns about fraud in digital payments and could set a precedent for how financial institutions are held accountable for safeguarding their customers against emerging threats in technology-driven finance.
Pre-Market Movers 📰📊
$NVO: Down 20.5% due to disappointing late-stage trial results for weight-loss drug CagriSema, benefiting rival Eli Lilly, which rose 6%.
$AVO: Up 11.7% after posting better-than-expected fiscal Q4 results, driving investor confidence.
$FDX: Up 8.7% after announcing a freight spinoff and exceeding Q2 EPS estimates, though revenue missed expectations.
$X: Down 6.8% after weak Q4 guidance forecasting a loss, missing analysts' expected per-share profit of 22 cents.
$NKE: Down 5.3% as revenue and earnings fell year-over-year despite topping low Wall Street expectations; turnaround plan faces delays.
$DJT: Down 3.1% after Donald Trump transferred his stake to a trust and a House spending deal backed by him failed.
$OXY: Up 2.7% following Berkshire Hathaway's disclosure of additional shares purchased.
$TSLA: Down 2%, extending losses amid market sell-off and profit-taking on election-related gains.
$MU: Down 1.8%, extending losses after disappointing Q2 guidance and worst one-day drop since March 2020.
$MSTR, $COIN, $HOOD: Down 1.1%-3.6% as falling bitcoin prices and fewer rate cuts weigh on markets.
$SBUX: Down 1% as baristas in major cities strike, demanding better wages and schedules; strikes may escalate.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
🚨 $PLTR Extends Partnership With U.S. Army. 🚨
Overview
➡️ Palantir Technologies has recently announced an extension of its partnership with the U.S. Army through a significant contract valued at $400.7 million.
➡️ This contract spans over a period of up to four years, with a total potential ceiling of $618.9 million.
➡️ The partnership, which began in 2018, has evolved to support various operational areas including logistics, recruiting, and readiness management, ultimately improving decision-making processes across the military.
➡️ The contract aims to enhance the Army Vantage capability, which is integral to the Army Data Platform (ADP) and supports over 100,000 users by integrating data from more than 180 unique sources.
Impact On Stock Price
➡️ Following the announcement of this contract extension, Palantir's stock (PLTR) experienced a positive market reaction.
➡️ On December 19, 2024, the stock rose by approximately 2.7%, reaching a high of $72.05 during trading.
➡️ This increase reflects investor confidence in Palantir's ongoing relationship with the U.S. Army and the potential for future growth stemming from the expanded capabilities and services provided under this contract.
Conclusion
➡️ The contract extension not only highlights Palantir's reliability and trustworthiness as a defense contractor.
➡️ It also positions the company to further leverage its AI-driven data solutions within military operations.
➡️ The continued support from the Army is expected to contribute positively to Palantir's financial outlook in the coming years.
Pre-Market Movers 📰📊
$LW: Down 20% after missing quarterly estimates and naming a new CEO amid activist investor pressure.
$MU: Down 11.2% on weak Q2 guidance despite Q1 earnings beat and revenue in line with expectations.
$DRI: Up 9.3% after earnings and revenue beat, with full-year revenue guidance raised to $12.1 billion.
$LEN: Down 8% on Q1 earnings miss, reporting $4.06 EPS vs. $4.16 expected, and revenue below estimates.
$KMX: Up 7.7% after Q3 results topped expectations with $0.81 EPS and $6.22B revenue.
$ACN: Up 5% on Q1 revenue beat and raised FY revenue growth forecast to 4%-7%.
$PLTR: Up 3.1% on expanded $619M U.S. Army partnership following a prior 4% drop during a market selloff.
$TSLA: Up 2.7% following an 8% selloff as markets reacted to fewer projected 2024 Fed rate cuts.
$CAG: Down 1.3% after cutting FY earnings guidance, though Q2 adjusted earnings and revenue beat estimates.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Market Recap📈📉
$RIVN: Down 11.2% after Baird downgraded to neutral, citing limited 2025 catalysts and sluggish EV sales projections.
$HEI: Down 8.6% after reporting weaker-than-expected revenue of $1.01 billion, missing analysts’ $1.03 billion forecast.
$JBL: Up 7.3% as earnings and revenue beat expectations, with $2 EPS on $6.99 billion revenue surpassing estimates.
$NTGR: Up 4.8% as the U.S. considers banning Chinese routers, positioning the U.S.-based company as a beneficiary.
$GIS: Down 3.2% after lowering its earnings outlook, forecasting a 1-3% adjusted EPS decline.
$EXPE: Up 2.4% after Bank of America upgraded to “buy,” calling it a top value stock in the internet sector.
$BIRK: Up 2% after exceeding expectations for Q4 earnings, revenue, and adjusted EBITDA.
$DIS: Up 1.5% after Morgan Stanley named it a top 2025 pick, citing substantial expected streaming profits.
$XMTR: Up 1.1% after JPMorgan upgraded to overweight, citing its status as a top secular growth story over the next 3-5 years.
$NVDA: Up 1.1% as shares rebounded from correction territory, extending their 2024 surge to over 175%.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Pre-Market Movers 📰📊
$JBL: Up 10.2% on stronger-than-expected Q1 earnings of $2/share and raised full-year revenue and EPS guidance.
$BIRK: Up 8.2% after Q4 EPS beat estimates at €0.29 vs. €0.26, with revenue up 21% year-over-year to €455.8M.
$XMTR: Up 6.7% after JPMorgan upgraded to overweight, praising its position as a top secular growth story for 3-5 years.
$HEI: Down 5.6% after mixed Q4 results with EPS slightly beating estimates but revenues missing FactSet's $1.03B projection.
$GIS: Down 4.4% after lowering 2025 EPS guidance to a decline of 3%-1%, below the previous range of down 1% to up 1%.
$OLLI: Up 3.2% after Citi upgraded to buy from sell, citing strong performance for its “good stuff cheap” retail model.
$NVDA: Up 2.6% after four losing sessions, rebounding from a 10% correction off its all-time high.
$RIVN: Down 1.4% after Baird downgraded to neutral, citing weaker 2025 EV sales expectations and few growth catalysts.
$MRK: Up 1% on a $2 billion deal to develop and commercialize Hansoh Pharma’s obesity drug, paying $112M for rights.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Market Recap📈📉
$QUBT: Up 51.5% after NASA awarded a prime contract for advanced imaging and data processing using Quantum’s Dirac-3 optimization machine.
$TEVA, $SNY: Up 26.4% and 6.7% after announcing positive Phase 2b results for duvakitug, their joint treatment for inflammatory bowel disease.
$SEDG: Up 16.6% following Goldman Sachs’ double upgrade to “buy,” citing 2025 as a key inflection point for its turnaround.
$AMENT: Down 9.6% after reporting a fiscal Q4 pro forma loss of 21 cents per share, compared to earnings of 17 cents per share last year.
$RCAT: Down 7.5% after reporting a Q2 loss of 18 cents per share, worse than last year’s 11-cent loss. Shares remain up 17% this week.
$PFE: Up 4.7% as the 2025 revenue outlook of $61-$64 billion matched Wall Street’s $63.22 billion consensus estimate, boosting investor confidence.
$AVGO, $NVDA: Down 3.9% and 1.2%, respectively. Nvidia fell into correction territory, while Broadcom surged 39% this week after strong earnings and topping $1 trillion market cap.
$TSLA: Up 3.6% as Mizuho upgraded to “outperform,” anticipating Tesla will benefit from upcoming regulatory changes under Trump, including autonomous driving.
$MANU: Up 3% after UBS initiated coverage with a “buy” rating, citing strong revenue potential that could drive profitability and performance.
$AFRM: Down 2.7% after announcing a $750 million private note offering and plans to repurchase up to $300 million in Class A stock.
$EPAM, $CTSH: Up 1.9% and <1% following Barclays’ upgrades to “overweight,” highlighting investments that position both companies well for returning sector demand.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Pre-Market Movers 📰📊
$RCAT: Down 14.9% due to a wider-than-expected quarterly loss of 18 cents per share, despite recent gains from drone funding speculation.
$SEDG: Up 13.8% following Goldman Sachs’ double upgrade to “buy,” citing a turnaround story with 2025 as a key inflection point.
$PFE: Up 2.4% after releasing a 2025 revenue forecast of $61-$64 billion, aligning with Wall Street’s $63.2 billion estimate.
$TSLA: Up 2.1% after Mizuho upgraded the stock to "outperform," predicting benefits from future regulatory changes under the Trump administration.
$NVDA: Down 1.9% as shares continue to slide after entering correction territory, diverging from $AVGO's strong 45% rally last week.
$HIMS: Up 1.5% as Morgan Stanley initiated coverage with an “overweight” rating, citing strong demand for personalized medication.
$ACI: Up 1.3% after Telsey Advisory Group upgraded the stock to “outperform,” showing confidence in growth potential following executive discussions.
$AVGO: Down 1.2% after a 45% surge last week, supported by an upbeat AI revenue forecast released Thursday.
$EPAM & $CTSH: Up both up ~1% after Barclays upgraded both to “overweight,” citing strategic investments to win business in a recovering IT sector.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Market Recap📈📉
$RCAT, $UMAC: Up 27% and 18.6%, driven by $PLTR partnerships and drone sightings.
$AVGO: Up 11.2% after stellar Q4 results, adding to its 24% surge last week and hitting a $1 trillion market cap.
$SMCI: Down 8.3% as concerns mounted over missed filings and a potential Nasdaq delisting despite CEO reassurances.
$MU: Up 5.6% as anticipation grows for strong quarterly earnings, bolstered by a positive JPMorgan note.
$F: Down 3.9% after Jefferies downgraded the stock to underperform, citing concerns about next year’s inventory overhang.
$CPRI: Up 3.8% as reports suggested the company is exploring selling Versace and Jimmy Choo via Barclays.
$HON: Up 3.7% after announcing a board exploration of splitting its aerospace division, supported by Elliott Management.
$GOOGL: Up 3.6% after reaching a new 52-week high, bolstered by Jefferies’ bullish 2025 tech stock outlook.
$KEYS: Up 2.6% after JPMorgan upgraded the stock, citing expectations of a cyclical recovery in 2025.
$NVDA: Down 1.7% as the AI chipmaker officially entered correction territory after a month of volatile trading.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
🚨 $SMCI Announces Capital Raise. 🚨
Overview
➡️ Super Micro Computer Inc. (SMCI) has engaged Evercore Inc. to assist in raising capital.
➡️ This move is aimed at stabilizing the company's financial position and avoiding potential delisting from Nasdaq.
➡️ This development comes in the wake of Super Micro's failure to file its annual financial report by the August deadline.
Reasons for Capital Raise
➡️ The primary motivation behind this capital raise is to address compliance issues and maintain Super Micro's Nasdaq listing.
➡️ The company failed to file its annual financial report on time, raising concerns about its financial reporting and internal controls.
Performance
➡️ Despite the current challenges, Super Micro reported strong financial results for fiscal year 2024, with net sales reaching $14.94 billion, a 110% increase year-over-year.
➡️ Super Micro's stock has experienced significant volatility recently.
➡️ The stock has fallen 69% from its peak in March 2024 with the news of the capital raise efforts leading to further declines; The stock is up 19% YTD.
Capital Raising Efforts
➡️ Super Micro is considering both equity and debt financing options.
➡️ One potential avenue being explored is a private investment in public equity (PIPE), which involves reaching out to private equity firms to gauge their interest in investing.
Governance Issues
➡️ Super Micro's auditor, Ernst & Young, resigned in October, citing governance concerns.
➡️ This led to the creation of an independent special committee to investigate the allegations, which found no evidence of misconduct by company management or the board.
Future Outlook
➡️ Despite the current challenges, Super Micro remains optimistic about its future.
➡️ The company has projected net sales of $26.0-$30.0 billion for fiscal year 2025, indicating confidence in its long-term growth prospects.
Pre-Market Movers 📰📊
$SMCI: Down 11.3% due to missed filing deadlines, raising Nasdaq delisting fears despite CEO reassurances
$CPRI: Up 4.6% as Barclays explores buyers for its Versace and Jimmy Choo brands.
$MSTR: Up 3.6% after being added to the Nasdaq-100 index.
$MU: Up 3.4% as JPMorgan expects strong quarterly earnings after Wednesday’s report.
$AVGO: Up 3.4%, extending gains after strong results pushed market cap above $1 trillion.
$KEYS: Up 3.3% after a JPMorgan upgrade citing cyclical recovery and leverage from the Spirent acquisition.
$MCHP: Down 3% following a Bank of America downgrade to underperform.
$F: Down 3% as Jefferies downgraded to underperform, citing concerns about inventory overhang and valuation.
$HON: Up 2.2% after announcing its board is exploring a potential separation of its aerospace division.
$AXON: Up 1.6% on news of joining the Nasdaq-100 later this month.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
Market Recap📈📉
$AVGO: Up 24.4% due to strong earnings, AI revenue tripling, and custom AI chip development, pushing market cap above $1 trillion.
$RH: Up 17.1% after forecasting 18%-20% revenue growth for Q4, citing demand acceleration and a swing to profitability.
$TASK: Up 15.6% after Morgan Stanley upgraded to overweight, highlighting strong margins, competitive moat, and AI growth potential.
$UPST: Up 9.6% following Needham’s upgrade to buy, citing improved funding balance and strengthened balance sheet after refinancing.
$WBA: Up 6.8% on reports Sycamore Partners is securing funding for a potential buyout, boosting investor confidence.
$CIEN: Up 6.1% after Bank of America upgraded to buy, noting stabilizing demand, AI/cloud growth, and lifted fiscal 2025 revenue guidance.
$TSLA: Up 4.3% after reports of Trump team recommending removal of crash reporting disliked by Musk, easing Tesla’s compliance burden.
$PENN: Up 3.9% as JPMorgan upgraded to overweight, citing strong growth potential from capital projects and double-digit returns forecasted.
$CSIQ: Up 2.5% after Mizuho initiated outperform rating, noting undervalued energy storage business growth.
$CNC: Up 2.4% after UBS upgraded to buy, calling the stock “too cheap to ignore” amid favorable valuation.
$NOW: Down 2.3% after KeyBanc downgraded to sector weight, citing limited upside despite AI leadership.
$PYPL: Up 1.8% after Wolfe Research upgraded to outperform, citing strong monthly active user base and upside potential in Wall Street estimates.
$CRM: Down 1% as KeyBanc upgraded to overweight but flagged room for improvement after recent rally.
🚨 Follow @TraderverseNews for Your Daily Trading Reports!
🚨 VanEck's Predicts New ATHs for $BTC, $ETH, & $SOL in 2025. 🚨
Bitcoin (BTC)
➡️ Matthew Sigel, head of digital assets research at VanEck, predicts that Bitcoin could peak at $180,000 during the current rally, which is expected to continue into 2025.
➡️ This projection draws parallels to previous market behaviors following significant political events, such as the 2020 U.S. presidential election, where Bitcoin experienced substantial growth.
➡️ Jan van Eck, CEO of VanEck, has a more audacious long-term forecast stating that Bitcoin could reach $300,000 within 5-10 years, primarily due to its potential to capture a significant portion of the gold market as a digital alternative.
Ethereum (ETH)
➡️ VanEck forecasts that Ethereum could surpass $6,000 in 2025.
➡️ This expectation is based on increased activity within its ecosystem, particularly through Layer-2 solutions which are anticipated to attract significant investment flows from institutional investors.
Solana (SOL)
➡️ VanEck predicts that it could reach $500 in 2025.
➡️ This growth is attributed to its low transaction fees and an expanding developer ecosystem that supports various projects on its network.
➡️ There is optimism surrounding the potential approval of a Solana ETF by the end of 2025, which would enhance its institutional appeal and market presence.